Metformin Inhibit Cervical Cancer Migration by Suppressing the FAK/Akt Signaling Pathway

Henna Hakimee1, Pilaiwanwadee Hutamekalin2, Supita Tanasawet3

  • 1Department of Pharmacology, Faculty of Science, Prince of Songkla University, Hat Yai, Songkhla, Thailand.

Abstract

Insights

Metformin significantly inhibits cervical cancer cell migration by reducing cell structures like filopodia and lamellipodia. This antimetastatic effect is mediated by suppressing key proteins involved in cell movement.

Area of Science:

  • Oncology
  • Pharmacology
  • Cell Biology

Background:

  • Metformin, an established antidiabetic medication, exhibits potential anti-cancer properties.
  • The specific impact of metformin on cancer cell migration, particularly in cervical cancer, requires further elucidation.

Purpose of the Study:

  • To investigate the effect of metformin on the migration of cervical cancer cells.
  • To explore the underlying molecular mechanisms responsible for metformin's influence on cell migration.

Main Methods:

  • Cervical cancer cell lines were treated with metformin.
  • Immunocytochemistry and Western blotting assays were employed to analyze protein expression and cellular structures.

Main Results:

  • Metformin treatment markedly reduced the migratory capacity of cervical cancer cells.
  • Filopodia and lamellipodia formation were significantly diminished post-metformin exposure.
  • Metformin suppressed key regulatory proteins including focal adhesion kinase (FAK), Akt, Rac1, and RhoA.

Conclusions:

  • Metformin demonstrates antimigratory effects in cervical cancer by inhibiting filopodia and lamellipodia formation.
  • This inhibition occurs through the downregulation of FAK, Akt, Rac1, and RhoA signaling pathways.
  • Metformin presents a potential therapeutic candidate for managing cervical cancer metastasis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K